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Mechanisms in B-cell Neoplasia. Current Topics in Microbiology and Immunology Vol. 194; Edited by M. Potter and F. Me1chers; 
Springer-Verlag; Berlin, Heidelberg. New York, 1994; xiii + 458 pp. DM 218.00. ISBN 3-540-58447-1 
The 12th workshop on 'Mechanisms In B-cell Neoplasia' was held In 
Bethesda. MD, in June 1994. organised mainly by Dr. Alan Rabson at 
the NatIOnal Cancer Institute. A book In the Current TopIcs in 
MicrobIOlogy and Immunology (CTMI) series (number 194) report 
from this meetIng. edited by Michael Potter and Fntz Melchers. 
The maIn tOpICS covered were multiple myeloma (MM) 
plasmocytoma. human and mome B-cell lymphomas. growth 
regulatIOn OL-6. c-myC'. Bcl-'2. cyclin DI and ABU and genomic 
instability 
MM. which IS becoming a more common malignant disease. was 
discussed from many different aspects. IncludIng pre-myeloma cells. 
expreSSIng an Ig Idiotype. as Initially desCrIbed by Mellstedt et al (ClIn. 
Exp. ImmunoI.. 17. 371. 1974). The~e cells were Invesligated by more 
sensitive techmques for clonality. IncludIng PCR and DNA 
fingerprintIng. These pre-myeloma cells caused a problem In 
autologous bone-marrow transplantatIOn. due to their ill-defined 
phenotype marker expressIOn In relatIOn to CD34 expression. An even 
earlier stage of MM may relate to a conditIOn called Monoclonal 
Oamopath) of Undetermined Slgmficance (MOUS). ocurrIng of 3% of 
the population over 70 years of age. A large percentage of these MOUS 
patients were reported to develop Into MM. Surface Ig on pre-myeloma 
cells may bInd autoantigens and thereby upregulate surt~\Ce molecules 
involved In B cell activatIOn and differentiation. 
The deregulatIOn of C-III)'C IS Important in many types ofB cell tumors 
In relation to the cellular control of mitotic cycling and apoptosis. Myc. 
and myc heterodlmers. bInd to regulator) motifs in DNA and thus 
regulate the expressIOn of dliTerent genes An Increase In c-!nrc also 
leads to the accumulatIOn of cells In 0 liS for further progressIOn to 
death by apoptosls. 
IL-6 was Implicated as a growth and maturation factor for plasma 
cell tumors. IL-6 was found to activate different transduction pathways 
induding Immediate JAK-STAT and delayed. yus-dependent kmases 
and CD40-dependent signalling may Induce autocrine IL-6 productIOn 
B cell regulatIOn by IL-6 Illustrate the complexity of signalling by 
cytokines that can modulate transcriptional factors important for 
termInal differentiation. The importance of IL-6 bIndIng to the IL-6 
receptor and signal transducer was approached by Isolating a soluble 
form of the IL-6 receptor (sIL-6R) and an lysIng the effect of other 
growth factors that share the same signal transducer (gpI30). 
Oenomic Instability was studied in relation to VDJ rearrangement;,. 
and heavy chaIn Isotope switchIng. and the translocatIOn of other. 
non-Ig regIOns. includIng target genes. such as c-myc. Bcl-'2. pl't-l and 
others. The PCR technique was used to further charactense 
chromosomal translocatlOns in relatIOn to the natural history of 
lymphoma developmcnt and the IdentificatIOn of some of these also In 
non-neoplastic tissues. 
Orowth regulation by the Bcl-'2 gene family was discussed. 
HeterodlmenzatlOn With Bax was presented as a possible mechamsm 
for BcI-'2 to repress cell death. This Information needs only to be 
completed With the latest descnptlOns of other survival genes. such a, 
BAG-I and Bud (Takayama et a!.. Cell 80:'229 and Yang et al. Cell 
80.285). Bcl-'2 overexpres;,lOn In B-CLL IS assOCiated With Increased 
accumulatIOn of B-CLL cells and apoptosls InhibitIOn BcI-2 was 
proposed to regulate calcIUm release and to have antIOxidant actIVIty 
to explain its protective potential agaInst different conditIOn;, that 
Induce apoptosls 
These are Just a few of the many reports (54) written by leadlllg 
workers m the field. The book focuses on important. 'hot' areas m 
mechamsms In B-cell neoplaSia and IS a nch ;,ource of informatIOn both 
for climcal and baSIC SClcntlst, 
M.loudal 
Alzheimer Disease: Therapeutic Strategies; Edited by E. Giacobini and R. Becker; Birkhauser; Boston. 1994; xiv + 509 pp. $ 74.50. 
ISBN 0-8176-3757-5 
Alzhelmer\ disease (AD) IS major cause of dementia. and a major 
health problem, With suffenng both for the affected and their relatives. 
and enormous costs for the society. The last years have also seen a 
weaIth of studies to charactense the neurochemical pathology of AD. 
ThiS knowledge forms the platform for therapeutic strategies and 
attempts to develop ne", drugs for the disorder. Indeed. AI::helmer 
DIsease TherapeutIc Strategies. the third publication in a senes on 
Alzheimer therapy. edited by Olacobmi and Becker. gives a welcome 
extensive update on these tOpiCS. 
The chohnergic hypothesis still has a central role m AD therapeutics. 
receIVIng almost half the space in the book. The leadmg therapeutic 
approach almmg at mcreasing cholmerglc neurotransmlsslon in AD IS 
by means of cholinesterase mhlbltor (ChEll. Indeed. the only registered 
compound for treatment of the cogmtlve symptoms m AD is a ('hEr. 
namely tetrahydroammoacndIne. or tacrine. Although 13 chapters go 
through ChEIs. also other compounds almmg at enhancing the 
cholinergic system are covered. mcluding several chapters on mcotinic 
and muscanmc agomsts. 
However. a IS clear that multiple neurotransmitter systems are 
disturbed in AD One of these IS the serotonmerglC system, reViewed 
In the chapter by Oottfnes. Patients with AD suffer not only from 
memory disturbances and other cogmtlve symptoms. but abo from 
emotIOnal disturbances Treatment wah selective serotomn re-uptake 
mhlbltors. such as cltalopram. reduce emotIOnal disturbances such as 
IrrItability. anxiety. and depreSSIOn These symptoms may. in the earlier 
stages of the disorder. often cause more discomfort than the cognitive 
symptoms. 
Other therapeutIC approaches m AD mcludes nootroplc. antiOXidant 
and antl-mflammatory agents. In the chapters by McOeer and co-
workers and by Webster and Rogers. evidence for an inflammatory 
component m the pathogeneSIs IS reViewed Interestmgly. also a 
prelimInary climcal tnal usmg the non-sterOidal anti-Inflammatory 
drug mdomethacm. support that anti-inflammatory agents may be 
benefiCial for the treatment of AD. 
Several chapters discuss therapeutic strategies aImmg at arresting the 
deposition of amyloid is the bram. The pros and cons concerning the 
amylOid cascade hypothesis are weighed In the chapter by Hardy and 
Duff. Accordmg to the hypotheSIS. fJA4 protem depOSitIOn IS the central 
event m the pathogeneSIs of AD. which IS regarded an amylOid storage 
disease of the brain Amyloid depOSitIOn IS regarded to start a cascade 
of events that finally results in the dementia that bnngs the patient to 
the phYSICian. The essential predictIOn In the amylOid cascade 
hypotheSIS IS that fJA4 protem. or aggregates of fJA4 protem. IS 
neurotoxIc. ThiS has been both ntenslvely tested (m ammal 
expenments and cell culture systems). and debated (In a whole Issue of 
Neurobiology of Agmg) In fact. a book on therapeutic strategies tor 
AD IS an excellent forum to diSCUSS the amylOid cascade hypotheSIS. 
smce the real challenge for the amylOid cascade hypotheSIS Will not 
come untlll drugs that (In cell culture or ammal models) arrest amylOid 
depOSitIOn can be tested In IIvmg patients with AD. to sec If they also 
arrest the progressIOn of the disease. 
Nine chapters are devoted to the issue of momtonng the drug by 
different Imagmg techmques (e g. SPECT and PET) and by climcal 
testing (using different rating scales). However. although eVidence are 
accumulatmg that what today IS called 'Alzheimer's disease' actually IS 
a heterogeneous syndrome. no chapter diSCUSS whether the drug effect 
may vary between AD patients With different aetIOlogy (e g rare genetIC 
forms vs. common sporadiC forms) and pathogeneSIs (e.g. patients With 
or Without nsk-factors such as the ApoE4 allele or concomitant 
vascular diseases). Moreover. It IS also logical to as;,ume that the 
pathogeneSIs In the rare cases With early-onset sporadiC AD (wIth onset 
40- 65 years of age) IS not Identical to that In elderly patients 80 90 years 
of age (where AD pathology IS found In almost all mdmduals. and 
25-40% has dementia). Thus. also the chmcal response to different 
drugs may vary between these patients ConseLJuently. a chl1lcal 
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response to a drug may be overshadowed, If It IS tested without 
considering subgroups of AD. ThIs problem is only considered m the 
chapter by Svennerholm and Toffano, m whIch a study is presented 
where ganglioside GMI, a glycosphingolIpld with neuroprotective and 
neurotrophIc effects, is given by continuous mtracerebroventricular 
mfusion to patients with the classIcaL early onset, form of AD. 
Anyhow, Alzheimer Disease Therapeutic Strategies encapsulates the 
present knowledge in AD therapeutIcs, as well as the underlymg 
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neurochemical pathology for compounds that today :!re clImcally 
avaIlable (e.g. tacrine, citalopram) or under clImcal trials (e.g. antI-
mflammatory agents), and also reviews potential future therapeutIc 
approaches (e.g. agents almmg at arresting amylOId deposition), a 
concept whIch must mterest both scientists mvolved m AD research and 
clImcIans. 
K. Blennow 
Dictionary of Gene Technology; Edited by G. Khal; VCH; Weinheim New York, 1995; xii + 550 pp. DM 184.00. ISBN 3-527-30005-8 
The Dictionary oj Gene Technology presents a large collection of terms 
and laboratory jargon used m the field of genetic engineering and 
related areas. In the preface the author states that gene technology IS 
an extremely rapid growing science and anybody can agree with that 
The book represents an immense piece of work and It IS Impressing that 
It has been possible to compile so many terms that are presented m a 
clear \'lay and m general are explamed and descnbed m as much detaIl 
as is reqUIred to understand them. Each entry contams many cross 
references to other entnes in the book and many of the descnptlOns are 
supported by good illustratIOns. 
The areas covered go far beyond the broad field of gene technology, 
touching many related diSCIplInes that mclude microbIOlogy, genetics. 
chemistry and biochemistry. Although the dictionary compnses several 
thousand entnes a certain selection seems to have taken place For 
example, the book includes descnptlOns of several protein motIfs lIke 
zmc fingers, leucine zippers, helix-tum-helIx and helix-loop-hehx motIfs 
whIle other well known motifs, e.g. the RNA recogmtlOn motif and the 
EF-hand motif are left out. Perhaps this has to do wIth a predisposition 
to favour protems that may interact with DNA. Furthermore, with such 
a huge dIctionary It may be unavoidable that some terms are less 
adequately descnbed. As stated m the preface the author is fully aware 
of this. To mention a few, homology IS defined as the extent of IdentIty 
between two nucleotide or amino aCId sequences. Although thIS 
mterpretatlon IS WIdely used in the hterature the author misses the 
precIse bIOlogical meaning, I.e. having a common evolutionary origin. 
Another entry, eqUlhbrium dIalysis, is rather clumsy defined as a 
method to determme protein-protein interactIOn wIth a description of 
a very specIal case, omitting the essence that It IS a method to determine 
the bmdmg strength of a low molecular mass ligand, that can pass 
through a dIalYSIS membrane, to a high molecular mass macromolecule 
that cannot pass through the membrane. However, it would be out of 
proportion to highlight a few terms that clearly represent exceptIons to 
the rule WIthout emphaslsmg that there are more than 4000 useful 
entries the great maJonty of whIch are adequately described. 
The book IS mamly addressed to students m the field of gene 
technology and scientists In related fields who are unfamlhar or only 
slightly famIliar with recombInant DNA technology. Undoubtedly the 
dIctIOnary WIll find a natural place m molecular bIOlogy laboratones 
that frequently host guests. The book proVIdes Information whIch is not 
eaSIly percel\ed from other sources and It can be hIghly recommended. 
Bent Honore 
Molecular and Cellular Enzymology. Progress in Molecular and Subcellular Biology; Edited by Ph. Jeanteur; Vol. 13: Springer-Verlag; 
Berlin, Heidelberg, 1994. x + 150 pp. DM 198.00. ISBN 0-387-57337-2 
EnzymologIsts frequently suffer from the delusion that the enzyme 
properties that they observe m vItro are the same as those in the cell. 
This book will rapidly destroy such illUSIOns but also suggests ways of 
studymg the mtracellular behavious of enzymes. It IS a collectIOn of 
three very different articles on proteins withm cells: the unifying theme 
is that proteins, particularly enzymes, WIll be affected by the 
microenVIronment in the cell. All the artIcles are written by active 
workers m theIr fields but they dIffer m the commItment demanded of 
the reader. 
The first chapter makes up more than half the book and IS a detaIled 
examination of the modelling of enzyme dynamICs m cells The 
approach is theoretical with many mathematIcal formulae whIch need 
to be grasped if the full thrust If the authors' argument is to be followed 
but the effort is very worthwhile. The foundatIOn of the analysis is that 
the mtenor of a cell, particularly the membranes, can be regarded as 
a charged ionic matrix. The flow of charged particles through such a 
matrix is examined WIth partIcular reference to ATP-synthase. 
Examination of the effects of dIffusion coupled to enzyme actIvity leads 
to the surpnsmg finding that the actiVIty of an enzyme under such 
conditions can vary, at the same concentratIOn of substrate, accordmg 
to whether substrate concentration is mcreasing or decreasing. The 
authors then discuss the effect on an enzyme of bemg mserted In a 
charged environment and conclude with a conSIderation of the 
dynamICs of feedback control and multI-enzyme systems. The 
theoretical ideas are Illustrated by experimental examples. 
The next chapter revIews mIcrobIal and genetic approaches to the 
study of proteins. Various approaches to pomt mutation of proteIns are 
descnbed, m particular the use of amber codons together WIth amber 
suppressor tRNAs to generate protein vanants WIth up to 13 different 
ammo acids at the same position. The authors' work on a cellulase IS 
used as an illustratIOn of the technique. Such multI replacement allows 
the sensitivity of protein functIOn to the presence of particular residues 
to be determined. The use of mserted tryptophan residues to stduy 
conformatIOnal changes in calmoduhn IS also descnbed. 
The final chapter IS an excellent review of fluorescence spectroscopy 
as applied to the study of single cells. The article ranges from details 
of fluorescence quenching, energy transfer, polarisatIOn and anisotropy 
through to use of lifetimes and confocal mIcroscopy. This is very much 
a quick tour around the expenmental advantages and hazards of 
fluorescence techmques. It would form a SUItable introduction for final 
year undergraduates. 
Overall thIS book presents several perspectives on the effect of the 
cellular environment upon enzymes. It makes us stop and think what 
we are really trying to achieve when we study our enzymes outside the 
cell 
Alan Thomson 
